UPDATE: Full GAO Report on FDA's "Unusual" Plan B Decision Released

We reported last month on the intial findings of the Government Accountability Office's (GAO) report on the FDA's decision to deny the sale of Plan B over-the-counter. The full report, titled Decision Process to Deny Initial Application for Over-the-Counter Marketing of the Emergency Contraceptive Drug Plan B Was Unusual is now available on the GAO's website.

TO READ MORE, CLICK HERE (PDF)